Trials / Unknown
UnknownNCT04007653
Long-term Outcome After Edoxaban Versus Vitamin K Antagonists for Acute VTE
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (estimated)
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The HOKUSAI post VTE study contains of two different research questions; one on the long term outcomes of deep vein thrombosis and one on the long term effects of pulmonary embolism, post thrombotic syndrome (PTS) and chronic thromboembolic pulmonary hypertension (CTEPH) respectively. Our aim of the study is to compare the long term outcomes along with the quality of life assessment of VTE in a group treated with heparin+VKA versus a group treated with heparin+edoxaban in the acute setting.
Conditions
- Venous Thromboembolic Disease
- Post Thrombotic Syndrome
- Chronic Thromboembolic Pulmonary Hypertension
- Quality of Life
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observation | No intervention |
Timeline
- Start date
- 2017-04-25
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2019-07-05
- Last updated
- 2019-07-05
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04007653. Inclusion in this directory is not an endorsement.